ZIM Laboratories Limited (BOM:541400)

Market Cap	7.80B +128.4%
Revenue (ttm)	3.97B +7.5%
Net Income	36.96M -60.6%
EPS	0.74 -61.9%
Shares Out	53.66M
PE Ratio	197.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,231
Open	133.50
Previous Close	139.95
Day's Range	133.50 - 148.20
52-Week Range	59.72 - 160.10
Beta	0.82
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About ZIM Laboratories

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, directly compressible granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 632
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 541400

Financial Performance

In fiscal year 2026, ZIM Laboratories's revenue was 3.74 billion, a decrease of -1.22% compared to the previous year's 3.79 billion. Earnings were 58.38 million, a decrease of -52.01%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 17, 2026

Data Sources Report a data error